November 29, 2012 – An Ohio woman has filed a wrongful death lawsuit against the maker of GranuFlo, a controversial dialysis treatment product, after it allegedly caused her husband to suffer a fatal cardiac arrest. According to the complaint, Fresenius Medical Care (FMC), the company that manufactures GranuFlo, is responsible for the death for failing to provide adequate warnings about its product’s potential to cause adverse health complications. Fresenius has been at the center of considerable controversy since March, when a secret internal memo was leaked to the FDA revealing that the company had failed to provide proper instructions about how to administer GranuFlo to doctors outside its own clinics.
July 2013 – Michael Schmidt Elected to Plaintiffs’ Steering Committee For Granuflo and Naturalyte Injury Claims Nationwide
GranuFlo Lawsuit Update 5/8/14: Lawyers involved in the nationwide GranuFlo litigation are expected to meet this week with a U.S. district judge to review proposals regarding preparation for the upcoming bellwether trials. Fresenius Medical Care (FMC), the company that manufactured GranuFlo, currently faces about 1,500 federal complaints from patients who allegedly suffered cardiac arrest or sudden death after undergoing dialysis treatment with the product. Click here to learn more.
GranuFlo Lawsuit Update 3/12/13: At least four separate GranuFlo and NaturaLyte class action lawsuits have been filed against DaVita Healthcare, alleging that the company should have known about the dialysis products’ potential to cause severe, potentially life-threatening side effects. The complaints seek class action status to include all patients who underwent hemodialysis treatment with GranuFlo or NaturaLyte at a DaVita clinic. Click here to learn more.
Free GranuFlo Lawsuit Evaluation: If you or a loved one has been injured by GranuFlo, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of GranuFlo and we can help.
What’s the problem?
The new GranuFlo Cardiac Arrest Lawsuit was filed on November 13 in the U.S. District Court for the Southern District of Ohio by Deborah Swigert on behalf of her late husband, Charles M. Swigert. According to the complaint, Swigert experienced a catastrophic cardiac arrest while undergo dialysis treatment at a Fresenius clinic in Washington Court House, Ohio. He was rushed to a local hospital, where he was later pronounced dead. Swigert was 56.
The lawsuit joins a growing number of similar claims filed against Fresenius in courthouses around the country on behalf of individuals who died or suffered catastrophic injuries after undergoing dialysis treatments with GranuFlo. According to the majority of these complaints, GranuFlo contains sodium acetate which allegedly converts to bicarbonate at higher levels than rival products, requiring close monitoring of dialysis patients‘ bicarbonate buffer prescriptions to reduce the risk of adverse cardiovascular reactions.
In November 2011, Fresenius circulated an internal memo to doctors at its own clinics warning about the risks of using GranuFlo during dialysis treatment procedures. The memo highlighted the importance of monitoring pre-dialysis bicarbonate levels and adjusting dialysate prescriptions to avoid complications during dialysis. A review of patients at the company’s own clinics found at least 940 instances where patients suffered cardiac arrest during dialysis treatments in the year 2010 alone.
Yet despite having knowledge of GranuFlo’s ability to cause serious side effects, FMC chose not to share this information with the public or medical communities outside its own facilities. It wasn’t until March 2012, when a copy of the memo was leaked to the U.S. Food & Drug Administration (FDA) did the public become aware of this situation. After receiving the memo, the FDA promptly issued a nationwide Class I Recall for GranuFlo and NaturaLyte (another dialysis treatment product made by Fresenius) on March 29.
Do I Have a GranuFlo Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in GranuFlo lawsuits. We are handling individual litigation nationwide and currently accepting new GranuFlo injury and death cases in all 50 states.
Free GranuFlo Lawsuit Evaluation: If you or a loved one has been injured by GranuFlo, you should contact our law firm immediately. You may be entitled to compensation by filing a GranuFlo injury suit and we can help.